Runs Equity Healthcare, which manages medical benefits spending across Blackstone's portfolio companies; joined Blackstone in 2013.
| What Could Go Wrong Covering High-Cost Claimants With Stop-Loss Reinsurance? EP479. | Relentless Health Value | 2025-06-12 | Stop-loss carriers shoot for 30 to 40% margins on the policies they sell. That figure came from the CEO of a large stop-loss carrier, in what Andreas Mang describes as a moment of weakness. If you're a self-insured employer and you haven't been actively marketing your stop-loss coverage every year, you may be paying hundreds of thousands — or millions — of unnecessary dollars for too much insurance, or the wrong kind. In this second conversation, Stacey Richter speaks with Andreas Mang, Senior Managing Director at Blackstone and CEO of Equity Healthcare, and Jon Camire, Managing Director, CFO of Equity Healthcare, and actuary, about the advanced considerations in stop-loss coverage for high-cost claimants — the contract provisions most plan sponsors overlook, the eligibility gaps that surface at the worst possible moment, and how to use a panel approach to let market forces work in your favor. | |
| EP478: Stop-Loss Coverage, Part 1: How It Goes Right, and How It Can Go Horribly Wrong, With Andreas Mang and Jon Camire | Relentless Health Value | 2025-05-29 | Stop-loss is one of the most important buying decisions a self-insured employer makes — and it's almost always the last one, made when everyone is exhausted and ready to just be done. That combination has produced some expensive disasters. This episode is the 101 that makes sure you don't create one. Stacey Richter speaks with Andreas Mang, Senior Managing Director at Blackstone and CEO of Equity Healthcare, and Jon Camire, Managing Director, CFO of Equity Healthcare at Blackstone, and actuary, about what stop-loss coverage actually is, how individual and aggregate policies work, and — most importantly — why a laser claim is not always the bad news it sounds like. | |
| Encore! EP419: The Financialization of Health Benefits for Boards of Directors and C-Suites of Self-Insured Employers, With Andreas Mang | Relentless Health Value | 2024-12-19 | Are you on the board of directors of a company? Or a shareholder of a publicly traded company? Or a CEO, CFO, or in-house counsel who reports to a board of directors or shareholders? This encore episode is for you — it's about how the healthcare industry has become financialized at the same time that providing health benefits has become the second-biggest line item after payroll for most companies (a topic touched on in the recent encore with Mark Cuban, EP418, as well as the show with Cora Opsahl, EP452, and Claire Brockbank, EP453, from 32BJ). In this encore episode, Stacey Richter interviews Andreas Mang from Blackstone about the financialization of health benefits for boards of directors and C-suites of self-insured employers. They discuss the unseen financial layers in healthcare benefits and how companies can save significantly while improving employee satisfaction and health. WHAT YOU'LL LEARN ✅ Why Andreas starts every conversation with the question "How's your healthcare company?" | |
| EP442: A Short Rumination on Saving Money, Except Not Saving Money. Oncology Side Effect Management as a Case Study, With Andreas Mang | Relentless Health Value | 2024-06-27 | The number one cause of hospital readmissions during chemotherapy is dehydration — which is treatable with a simple, inexpensive anti-nausea medication. Stacey Richter plays an outtake from her earlier conversation with Andreas Mang of Blackstone's Equity Healthcare and then works through four ruminations sparked by it: why PBMs restricting nausea meds to save a few dollars can quietly generate thousands in downstream medical costs, and why fee-for-service so often fails to pay for the very side-effect management that keeps patients out of the ER in the first place. | |
| Executive Series: Blackstone’s Big Impact on Cost and Quality with Andreas Mang | The Beat | 2024-01-29 | ||
| The Financialization of Health Benefits for Boards of Directors and C-Suites of Self-Insured Employers, With Andreas Mang. EP419 | Relentless Health Value | 2023-11-30 | Are you on the board of directors of a company? A shareholder of a publicly traded one? A CEO or CFO who reports to a board? This episode is for you. Following up on last week's conversation with Mark Cuban (EP418), Stacey Richter talks with Andreas Mang, senior managing director and CEO of Equity Healthcare at Blackstone, about how healthcare has become financialized at the exact moment health benefits became most companies' second-biggest line-item expense — and about the concrete, unglamorous purchasing discipline that can claw back 10% or more of that spend while improving employee health. | |
| The Financialization of Health Benefits for C-Suites of Self-Insured Employers with Andreas Mang | Relentless Health Value | |||
| The HLTH Daily Show Ft. Andreas Mang, Blackstone, Senior Managing Director and Equity Healthcare CEO | Chitra Nawbatt | |||
| The Financialization of Health Benefits for Boards of Directors & C-Suites of Self-Insured Employers | Relentless Health Value |
RThe Financialization of Health Benefits for C-Suites of Self-Insured Employers with Andreas MangRelentless Health Value
CThe HLTH Daily Show Ft. Andreas Mang, Blackstone, Senior Managing Director and Equity Healthcare CEOChitra Nawbatt
RThe Financialization of Health Benefits for Boards of Directors & C-Suites of Self-Insured EmployersRelentless Health Value